Related Experiment Video
Updated: Jun 16, 2026

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation
Published on: September 19, 2019
Micro-orchestrating differentiation in cancer.
Riccardo Taulli1, Francesca Bersani, Carola Ponzetto
1Department of Anatomy, Pharmacology and Forensic Medicine and Center for Experimental Research and Medical Studies, University of Torino, Torino, Italy.
MicroRNAs (miRNAs) may unlock cancer cell differentiation by targeting epigenetic modifiers. This approach could offer a non-toxic treatment strategy for solid tumors, similar to current therapies for blood cancers.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
- Gene Regulation
Background:
- Cell differentiation involves epigenetic silencing of proliferation genes and activation of lineage-specific genes.
- Cancer cells exhibit a transcriptionally inactive state for differentiation genes, hindering therapeutic approaches.
- Current treatments for some hematologic malignancies utilize non-toxic differentiation induction.
Purpose of the Study:
- To investigate the potential of microRNAs (miRNAs) in overcoming the differentiation block in cancer cells.
- To explore the role of miRNAs in targeting epigenetic modifiers to restore gene expression.
- To assess the feasibility of a miRNA-based differentiative therapy for solid tumors.
Main Methods:
- Analysis of miRNA interactions with epigenetic modifier genes.
- Experimental manipulation of miRNA expression in cancer cell models.
- Assessment of gene expression changes related to differentiation and proliferation.
Main Results:
- Identification of specific miRNAs capable of targeting key epigenetic regulators.
- Demonstration that miRNA modulation can release the transcriptional block on differentiation genes.
- Evidence suggesting that miRNAs can induce differentiation in cancer cells.
Conclusions:
- MicroRNAs represent a promising therapeutic avenue for inducing cancer cell differentiation.
- Targeting epigenetic modifiers with miRNAs offers a potential non-toxic strategy for solid tumors.
- This approach could translate successful differentiative therapies from hematologic malignancies to solid cancers.
More Related Videos
09:52A Mimic of the Tumor Microenvironment: A Simple Method for Generating Enriched Cell Populations and Investigating Intercellular Communication
Published on: September 20, 2016
07:46Microfluidic Co-Culture Models for Dissecting the Immune Response in in vitro Tumor Microenvironments
Published on: April 30, 2021
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...